APC Panel Advises CMS To Review Brachytherapy Proposed Payment Rates
This article was originally published in The Gray Sheet
Executive Summary
High-dose-rate brachytherapy manufacturers Nucletron and Varian plan to survey all 600 U.S. hospitals performing the procedure in an attempt to convince CMS to raise the 2004 proposed payment rate under the hospital outpatient prospective payment system